iris dorbian

Pacific Growth Investors backs Originate Inc

Pacific Growth Investors LLC had made an investment in Originate Inc, a software innovation studio. No financial terms were disclosed.

Bringg amasses $12 mln

Bringg, a delivery logistics platform for businesses, has raised $12 million in funding. The investors were Dr. Shmuel Harlap, Eyal Ofer and Salesforce Ventures.

Tissue Analytics snaps up $5 mln Series A

Baltimore-based Tissue Analytics, a provider of wound and skin care solutions, has raised $5 million in Series A funding. DigiTx Partners led the round with participation from Tencent, Dreamit, Molnlycke Health Care, Intermountain Healthcare and Penn Medicine.

Xplorer Capital collects over $25 mln for third fund

Xplorer Capital has raised over $25 million for its third fund, according to an updated SEC filing. No target was listed on the document. The venture firm invests in internet and digital media businesses in emerging markets.

SV Health Investors promotes two

SV Health Investors has promoted Denise Marks to chief administrative partner from chief financial officer and Brent Faduski to chief financial officer from controller. Marks first joined the firm in 2003 while Faduski came on board in 2008.

Storage firm Closetbox inks $7.3 mln Series A

Denver-based Closetbox, a storage company, has secured $7.3 million in Series A funding. The investors in this round were not named.

Veeam Software buys N2WS for $42.5 mln

Veeam Software, a portfolio company of Insight Venture Partners, has acquired N2WS, a provider of cloud-native enterprise backup and disaster recovery for Amazon Web Services. The price of the transaction was $42.5 million.

Razorpay fetches $20 mln

Razorpay, an India-based payments solutions provider, has raised $20 million in funding according to a blog post. Tiger Global and Y Combinator led the round with participation from Matrix Partners.

Nyansa nets $15 mln Series B

Palo Alto, California-based Nyansa Inc, a provider of infrastructure management solutions, has secured $15 million in Series B funding. Intel Capital led the round with participation from Formation 8.

Aprinoia Therapeutics locks in $11.1 mln Series B

Aprinoia Therapeutics Inc, a clinical-stage neuroscience biotech company, focuses on tau, alpha-synuclein, and novel targets for neurodegenerative diseases, has closed $11.1 million in Series B funding. KTB Network and DCI Partners led the round with participation from ShangPharma Investment Group and TaiAn Technologies.